Technical Analysis for NMRD - Nemaura Medical Inc.

Grade Last Price % Change Price Change
F 0.08 -2.68% 0.00
NMRD closed down 2.68 percent on Monday, March 18, 2024, on 21 percent of normal volume. It ran into resistance at its 50 day moving average. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Up

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
50 DMA Resistance Bearish 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Narrow Range Bar Range Contraction -2.68%
Wide Bands Range Expansion -2.68%
Oversold Stochastic Weakness -2.68%
Boomer Buy Setup Bullish Swing Setup 3.90%

   Recent Intraday Alerts

Alert Time
60 Minute Opening Range Breakdown about 11 hours ago
50 DMA Resistance about 11 hours ago
20 DMA Resistance about 11 hours ago
10 DMA Support about 12 hours ago
60 Minute Opening Range Breakout about 12 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Nemaura Medical Inc. Description

Nemaura Medical, Inc. is a holding company. The Company owns a diagnostic medical device company specializing in discovering, developing and commercializing specialty medical devices. The Company's focus is on the development of a continuous glucose monitoring (CGM) device, which consists of a disposable patch containing a sensor, and a non-disposable miniature electronic watch with a re-chargeable power source. CGM through a non-invasive patch can enable early detection of subtle changes in blood glucose levels. The Company, through its operating subsidiaries, performs medical device research and manufacturing of a CGM, named sugarBEAT. The sugarBEAT device is a non-invasive, wireless device for use by persons with Type I and Type II diabetes, and may also be used to screen pre-diabetic patients. The sugarBEAT device extracts analytes, such as glucose, to the surface of the skin in a non-invasive manner where it is measured using sensors and interpreted using an algorithm.


Classification

Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Diabetes Medical Device Glucose Endocrine System Wireless Devices Blood Test Diabetes Mellitus Medical Monitoring Blood Glucose Monitoring Endocrinology Type I Diabetes Type II Diabetes Blood Sugar Level Continuous Glucose Monitor

Is NMRD a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 1.25
52 Week Low 0.068
Average Volume 62,940
200-Day Moving Average 0.39
50-Day Moving Average 0.08
20-Day Moving Average 0.08
10-Day Moving Average 0.08
Average True Range 0.01
RSI (14) 47.09
ADX 33.61
+DI 24.46
-DI 7.64
Chandelier Exit (Long, 3 ATRs) 0.09
Chandelier Exit (Short, 3 ATRs) 0.11
Upper Bollinger Bands 0.10
Lower Bollinger Band 0.07
Percent B (%b) 0.42
BandWidth 36.89
MACD Line 0.00
MACD Signal Line 0.00
MACD Histogram 0.0011
Fundamentals Value
Market Cap 2.31 Million
Num Shares 28.9 Million
EPS -0.39
Price-to-Earnings (P/E) Ratio -0.21
Price-to-Sales 766.31
Price-to-Book 122.56
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.09
Resistance 3 (R3) 0.09 0.09 0.09
Resistance 2 (R2) 0.09 0.08 0.09 0.09
Resistance 1 (R1) 0.08 0.08 0.08 0.08 0.09
Pivot Point 0.08 0.08 0.08 0.08 0.08
Support 1 (S1) 0.08 0.08 0.08 0.08 0.07
Support 2 (S2) 0.08 0.08 0.08 0.07
Support 3 (S3) 0.07 0.08 0.07
Support 4 (S4) 0.07